Life of Riley at Adeona with new CEO, CFO and directors
This article was originally published in Scrip
Executive Summary
Adeona Pharmaceuticals, a developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, has appointed its chair, Jeff Riley, president and CEO. Mr Riley has been a director at Adeona since 2010 and chair since November 2011. He most recently served as managing director of 526 Ventures.